HALEON PLC
LSE:HLN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
312.05
397
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
HALEON PLC
Investor Relations
In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe.
HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.
In the bustling world of consumer healthcare, HALEON PLC stands as a luminary figure, emerging with a focused mission: to deliver everyday health with humanity. Spun off from the pharmaceutical giant GlaxoSmithKline, HALEON now charts its independent course, concentrating on the development and distribution of over-the-counter medications, oral health products, and nutritional supplements. Its diverse portfolio includes household names such as Sensodyne, Panadol, and Centrum, demonstrating its wide-reaching impact on consumers’ health routines. These brands are not merely market fixtures; they represent HALEON’s commitment to blending scientific innovation with consumer insights, aiming to enhance well-being across the globe.
HALEON’s business model is poised at the intersection of healthcare and retail, thriving through an intricate blend of strategic marketing, global distribution networks, and strong brand equity. By leveraging extensive consumer research data, HALEON aligns its product offerings with the evolving needs and preferences of its audience. The company generates revenue primarily through product sales, employing an omnichannel strategy that ensures product availability across various retail and digital platforms. Its strategic alliances and network with pharmacies, supermarkets, and online marketplaces cement its accessibility and prominence in the market. Additionally, HALEON's stream of revenue is bolstered by its investment in innovation—a key driver that keeps its product lines relevant and competitive in a dynamic healthcare landscape.
Earnings Calls
Management
Brian James McNamara is the CEO of Haleon PLC, a leading global consumer health company. He played a significant role in the establishment of Haleon, which was spun off from GSK in July 2022 to focus on consumer healthcare products. McNamara has a strong background in both consumer health and the pharmaceutical industry, with extensive experience in leadership roles. Before becoming CEO of Haleon, McNamara was the CEO of GSK Consumer Healthcare, where he oversaw the consumer healthcare division, managing an extensive portfolio of brands across wellness, oral health, nutrition, and skin health. Under his leadership, the company has focused on innovation, growing its product line, and expanding into new markets. McNamara joined GSK in 2015 and has built a reputation for strong strategic vision and operational execution. Prior to his tenure at GSK, he held senior positions at companies like Novartis, where he was responsible for its over-the-counter (OTC) business. With a background in engineering and an MBA, McNamara is known for his analytical approach and his commitment to sustainable business practices. His leadership at Haleon is focused on improving global health outcomes by broadening access to healthcare products and solutions.
Before becoming CEO of Haleon, McNamara was the CEO of GSK Consumer Healthcare, where he oversaw the consumer healthcare division, managing an extensive portfolio of brands across wellness, oral health, nutrition, and skin health. Under his leadership, the company has focused on innovation, growing its product line, and expanding into new markets.
McNamara joined GSK in 2015 and has built a reputation for strong strategic vision and operational execution. Prior to his tenure at GSK, he held senior positions at companies like Novartis, where he was responsible for its over-the-counter (OTC) business.
With a background in engineering and an MBA, McNamara is known for his analytical approach and his commitment to sustainable business practices. His leadership at Haleon is focused on improving global health outcomes by broadening access to healthcare products and solutions.
Tobias Hannes Hestler is a recognized professional in the business and finance sectors, currently serving as the Chief Financial Officer (CFO) of Haleon PLC. He plays a pivotal role in managing the financial actions of the company, focusing on maintaining financial health, developing financial strategies, and contributing to the organization’s overall strategy. Haleon PLC, formerly a part of GlaxoSmithKline, is a prominent consumer healthcare company formed through the demerger of GSK's consumer healthcare division. With a wealth of experience in financial management and strategic planning, Hestler brings expertise in driving financial performance and supporting the company's growth objectives. His role involves overseeing financial operations, investor relations, and ensuring robust risk management to align with Haleon's goals. Under his leadership, the financial team at Haleon is instrumental in navigating the complexities of the consumer health market.
Claire Dickson is the Chief People Officer at Haleon PLC, a leading global company focused on consumer health. In her role, she is responsible for the company’s human resources strategy and operations, fostering an inclusive and positive workplace culture, and ensuring talent development aligns with the company's strategic goals. With a wealth of experience in HR leadership roles, Claire has been instrumental in implementing policies that support employee engagement, diversity, and development. Before joining Haleon, Claire held several senior HR positions in other major corporations, where she was recognized for her ability to lead transformative organizational changes and develop high-performing teams. Her expertise spans across various industries, enhancing her ability to adapt HR strategies to different business environments. Her leadership and commitment to cultivating talent have been crucial to fostering a dynamic and innovative corporate culture at Haleon. Claire holds degrees in Human Resources and Business Administration, which have provided a strong foundation for her successful career in people management and organizational leadership.
Before joining Haleon, Claire held several senior HR positions in other major corporations, where she was recognized for her ability to lead transformative organizational changes and develop high-performing teams. Her expertise spans across various industries, enhancing her ability to adapt HR strategies to different business environments. Her leadership and commitment to cultivating talent have been crucial to fostering a dynamic and innovative corporate culture at Haleon.
Claire holds degrees in Human Resources and Business Administration, which have provided a strong foundation for her successful career in people management and organizational leadership.
Sonya Ghobrial is the Head of Investor Relations at Haleon PLC, a global leader in consumer health. Bringing a wealth of experience in the financial sector, Sonya plays a pivotal role in managing Haleon's communication with the investment community, helping to accurately convey the company’s financial health and strategic direction. Before joining Haleon, she worked with prestigious organizations, holding significant roles such as the Head of Investor Relations at Avon Products and Director of Investor Relations at Imperial Brands. Sonya's expertise lies in financial analysis, strategic planning, and stakeholder engagement, making her a key figure in Haleon's efforts to maintain strong investor relations. Her educational background includes a solid foundation in finance, with qualifications that have prepared her for her influential roles in the corporate world.
Adrian Charles Morris is the General Counsel and Company Secretary at Haleon PLC. He plays a critical role in overseeing the legal and compliance functions of the company, ensuring adherence to regulatory requirements and providing strategic legal advice. With extensive experience in corporate law and governance, Morris contributes significantly to shaping the company's legal strategies and maintaining high standards of corporate governance. His leadership is instrumental in navigating the complexities of the healthcare and consumer goods sectors, in which Haleon operates.
Tamara Rogers serves as a Non-Executive Director at Haleon PLC, a prominent global consumer healthcare company. She brings extensive experience from her distinguished career in marketing, consumer goods, and the healthcare industry. Before joining Haleon, Rogers held several senior positions at Unilever, where she played a crucial role in driving global brand growth and product innovation. Her leadership has been characterized by a strong focus on consumer-centric strategies, digital transformation, and expanding market reach. Rogers’s insights and leadership skills have significantly contributed to shaping the strategic direction of the companies she has been involved with, including her impactful presence on Haleon’s board.
Filippo Lanzi is a prominent executive, known for his influential role at Haleon PLC, a company that operates in the consumer health sector. He serves as the Chief Marketing Officer (CMO), overseeing global marketing strategies that drive the company's growth and brand development. With a strong background in consumer goods and a keen understanding of market dynamics, Lanzi is responsible for enhancing Haleon's brand presence and consumer engagement on a global scale. His leadership in marketing is pivotal in ensuring that Haleon's products resonate effectively with consumers' health and wellness needs. Prior to his role at Haleon, Lanzi has had an extensive career in similar sectors, further strengthening his expertise in marketing and business development within the consumer health industry.
Keith Choy is a distinguished executive, currently serving as the President of Asia Pacific at Haleon PLC, a global company specializing in consumer health products. With a robust background in the healthcare sector, Keith Choy has accumulated extensive experience over the years, significantly contributing to the growth and strategic direction of the companies he’s been affiliated with. Before joining Haleon PLC, he held senior leadership positions at several leading pharmaceuticals and consumer health companies, where he was instrumental in driving market expansion and operational excellence. Known for his visionary leadership and strategic acumen, Choy has been pivotal in strengthening Haleon's presence in the Asia Pacific region through innovative practices, effective stakeholder engagement, and fostering a culture of performance and accountability. His expertise spans various areas, including business development, product management, and regional leadership, making him a vital part of Haleon’s executive team. Choy is also recognized for his commitment to developing sustainable business solutions that meet consumer needs while addressing the healthcare challenges specific to the diverse markets within the Asia Pacific region.
Before joining Haleon PLC, he held senior leadership positions at several leading pharmaceuticals and consumer health companies, where he was instrumental in driving market expansion and operational excellence. Known for his visionary leadership and strategic acumen, Choy has been pivotal in strengthening Haleon's presence in the Asia Pacific region through innovative practices, effective stakeholder engagement, and fostering a culture of performance and accountability.
His expertise spans various areas, including business development, product management, and regional leadership, making him a vital part of Haleon’s executive team. Choy is also recognized for his commitment to developing sustainable business solutions that meet consumer needs while addressing the healthcare challenges specific to the diverse markets within the Asia Pacific region.